LA, H., IS, Z., & PJ, M. (2015). Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: Implications for the treatment of multiple sclerosis. Brain research bulletin, 112, 42. https://doi.org/10.1016/j.brainresbull.2015.01.009
Chicago Style (17th ed.) CitationLA, Hammer, Zagon IS, and McLaughlin PJ. "Improved Clinical Behavior of Established Relapsing-remitting Experimental Autoimmune Encephalomyelitis Following Treatment with Endogenous Opioids: Implications for the Treatment of Multiple Sclerosis." Brain Research Bulletin 112 (2015): 42. https://doi.org/10.1016/j.brainresbull.2015.01.009.
MLA (9th ed.) CitationLA, Hammer, et al. "Improved Clinical Behavior of Established Relapsing-remitting Experimental Autoimmune Encephalomyelitis Following Treatment with Endogenous Opioids: Implications for the Treatment of Multiple Sclerosis." Brain Research Bulletin, vol. 112, 2015, p. 42, https://doi.org/10.1016/j.brainresbull.2015.01.009.
